Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000972900 | SCV001120630 | benign | not provided | 2023-08-04 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002382194 | SCV002695687 | likely benign | Cardiovascular phenotype | 2019-10-07 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV002479136 | SCV002803593 | likely benign | Lipase deficiency, combined | 2021-07-27 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000972900 | SCV004184494 | likely benign | not provided | 2023-11-01 | criteria provided, single submitter | clinical testing | LMF1: BP4 |